BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12562311)

  • 21. Immunotherapy for treating methamphetamine, heroin and cocaine use disorders.
    Xiaoshan T; Junjie Y; Wenqing W; Yunong Z; Jiaping L; Shanshan L; Kutty Selva N; Kui C
    Drug Discov Today; 2020 Mar; 25(3):610-619. PubMed ID: 31419495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.
    Kantak KM; Collins SL; Lipman EG; Bond J; Giovanoni K; Fox BS
    Psychopharmacology (Berl); 2000 Feb; 148(3):251-62. PubMed ID: 10755738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulating cocaine vaccine potency through hapten fluorination.
    Cai X; Tsuchikama K; Janda KD
    J Am Chem Soc; 2013 Feb; 135(8):2971-4. PubMed ID: 23398531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.
    Brimijoin S; Shen X; Orson F; Kosten T
    Expert Rev Vaccines; 2013 Mar; 12(3):323-32. PubMed ID: 23496671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential vaccine for cocaine abuse prophylaxis?
    Gallacher G
    Immunopharmacology; 1994; 27(1):79-84. PubMed ID: 8206756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human therapeutic cocaine vaccine: safety and immunogenicity.
    Kosten TR; Rosen M; Bond J; Settles M; Roberts JS; Shields J; Jack L; Fox B
    Vaccine; 2002 Jan; 20(7-8):1196-204. PubMed ID: 11803082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future potential for cocaine vaccines.
    Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR
    Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.
    Kosten TA; Shen XY; Kinsey BM; Kosten TR; Orson FM
    Am J Addict; 2014; 23(6):604-7. PubMed ID: 25251469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing cocaine-antibody interactions in buffer and human serum.
    Ramakrishnan M; Alves De Melo F; Kinsey BM; Ladbury JE; Kosten TR; Orson FM
    PLoS One; 2012; 7(7):e40518. PubMed ID: 22859949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.
    Brimijoin S
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):880-91. PubMed ID: 22229308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential vaccine for cocaine abuse prophylaxis.
    Bagasra O; Forman LJ; Howeedy A; Whittle P
    Immunopharmacology; 1992; 23(3):173-9. PubMed ID: 1500284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy for the treatment of drug abuse.
    Kosten T; Owens SM
    Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-cocaine vaccine development.
    Kinsey BM; Kosten TR; Orson FM
    Expert Rev Vaccines; 2010 Sep; 9(9):1109-14. PubMed ID: 20822352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune to addiction: the ethical dimensions of vaccines against substance abuse.
    Young MJ; Sisti DA; Rimon-Greenspan H; Schwartz JL; Caplan AL
    Nat Immunol; 2012 May; 13(6):521-4. PubMed ID: 22610239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of vaccines to help treat drug dependence.
    Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM
    Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications.
    Cohen PJ
    Drug Alcohol Depend; 1997 Dec; 48(3):167-74. PubMed ID: 9449015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical and policy issues in using vaccines to treat and prevent cocaine and nicotine dependence.
    Hall W; Gartner C
    Curr Opin Psychiatry; 2011 May; 24(3):191-6. PubMed ID: 21430537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against cocaine using a modifiable dendrimer nanoparticle platform.
    Lowell JA; Dikici E; Joshi PM; Landgraf R; Lemmon VP; Daunert S; Izenwasser S; Daftarian P
    Vaccine; 2020 Nov; 38(50):7989-7997. PubMed ID: 33158592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of vaccines in the management of addictive disorders.
    Orson FM; Kinsey BM; Singh RA; Wu Y; Gardner T; Kosten TR
    Curr Psychiatry Rep; 2007 Oct; 9(5):381-7. PubMed ID: 17915077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010.
    Kantak KM; Collins SL; Bond J; Fox BS
    Psychopharmacology (Berl); 2001 Jan; 153(3):334-40. PubMed ID: 11271406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.